Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D supplementation was linked to a significantly greater reduction in total PMS scores contrasted to the control group (n = 3 RCTs; SMD: −0.78; 95% CI [−1.30, −0.26]; p < 0.001; I2 = 58.22%) (Figure 3A).

Source: 3.4. Primary Outcome: PMS Total Score. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Source: Article title.

Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Systematic review · Journal of Clinical Medicine · 2026

Original publication title

Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amani Zainab; Reem Samir Tageldin; Rumaysah Patel; Mohamed Abdulrahim Hassan; Lama Atef Aburas; Marya Alkahily; Layan Shamsan; Salma Salman Al-Olaimat; Ashaz Sayeed; Ahmed Abu-Zaid

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Aim:

Premenstrual Syndrome (PMS) substantially impairs quality of life, while standard pharmacologic treatments are often limited by adverse effects or contraindications. This systematic review and meta-analysis evaluated the efficacy of vitamin D supplementation compared to passive control (placebo or standard care) for PMS symptom relief.

Methods:

PubMed, Web of Science, Scopus, Google Scholar, and CENTRAL were searched for randomized controlled trials (RCTs) up to January 2026. The primary outcome was change in total PMS severity scores. Secondary outcomes included depression, anxiety, physical symptoms, craving, and water retention. Standardized mean differences (SMDs) with 95% confidence intervals (CI) were pooled using a random-effects model. Heterogeneity was assessed using the I2 statistic.

Results:

Five RCTs including 436 participants were reviewed. The overall risk of bias was rated as “some concerns” in four RCTs and “low risk” in one trial. Vitamin D significantly reduced total PMS severity (SMD: −0.78, 95% CI: −1.30, −0.26, I2 = 58.22%) as well as physical symptoms (SMD: −1.00, 95% CI: −1.99, −0.01, I2 = 90.53%) and depression (SMD: −0.78, 95% CI: −1.53, −0.02, I2 = 84.56%). No significant effects were observed for anxiety, craving, or water retention. Vitamin D was well tolerated with no reported adverse events.

Conclusions:

Vitamin D supplementation may reduce overall PMS severity, particularly physical and depressive symptoms. However, results show substantial heterogeneity across outcomes, and the certainty of evidence remains “very low”, underscoring the need for further high-quality, well-powered RCTs.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Premenstrual Syndrome (PMS) substantially impairs quality of life, while standard pharmacologic treatments are often limited by adverse effects or contraindications. This systematic review and meta-analysis evaluated the efficacy of vitamin D supplementation compared to passive control (placebo or standard care) for PMS symptom relief.

Source: Aim

Abstract: Results

Five RCTs including 436 participants were reviewed. The overall risk of bias was rated as “some concerns” in four RCTs and “low risk” in one trial. Vitamin D significantly reduced total PMS severity (SMD: −0.78, 95% CI: −1.30, −0.26, I2 = 58.22%) as well as physical symptoms (SMD: −1.00, 95% CI: −1.99, −0.01, I2 = 90.53%) and depression (SMD: −0.78, 95% CI: −1.53, −0.02, I2 = 84.56%). No significant effects were observed for anxiety, craving, or water retention. Vitamin D was well tolerated with no reported adverse events.

Source: Results

Abstract: Conclusions

Vitamin D supplementation may reduce overall PMS severity, particularly physical and depressive symptoms. However, results show substantial heterogeneity across outcomes, and the certainty of evidence remains “very low”, underscoring the need for further high-quality, well-powered RCTs.

Source: Conclusions
Authors’ abstract

Aim:

Premenstrual Syndrome (PMS) substantially impairs quality of life, while standard pharmacologic treatments are often limited by adverse effects or contraindications. This systematic review and meta-analysis evaluated the efficacy of vitamin D supplementation compared to passive control (placebo or standard care) for PMS symptom relief.

Methods:

PubMed, Web of Science, Scopus, Google Scholar, and CENTRAL were searched for randomized controlled trials (RCTs) up to January 2026. The primary outcome was change in total PMS severity scores. Secondary outcomes included depression, anxiety, physical symptoms, craving, and water retention. Standardized mean differences (SMDs) with 95% confidence intervals (CI) were pooled using a random-effects model. Heterogeneity was assessed using the I2 statistic.

Results:

Five RCTs including 436 participants were reviewed. The overall risk of bias was rated as “some concerns” in four RCTs and “low risk” in one trial. Vitamin D significantly reduced total PMS severity (SMD: −0.78, 95% CI: −1.30, −0.26, I2 = 58.22%) as well as physical symptoms (SMD: −1.00, 95% CI: −1.99, −0.01, I2 = 90.53%) and depression (SMD: −0.78, 95% CI: −1.53, −0.02, I2 = 84.56%). No significant effects were observed for anxiety, craving, or water retention. Vitamin D was well tolerated with no reported adverse events.

Conclusions:

Vitamin D supplementation may reduce overall PMS severity, particularly physical and depressive symptoms. However, results show substantial heterogeneity across outcomes, and the certainty of evidence remains “very low”, underscoring the need for further high-quality, well-powered RCTs.

Publication and source details

Original title: Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amani Zainab; Reem Samir Tageldin; Rumaysah Patel; Mohamed Abdulrahim Hassan; Lama Atef Aburas; Marya Alkahily; Layan Shamsan; Salma Salman Al-Olaimat; Ashaz Sayeed; Ahmed Abu-Zaid

Journal of Clinical Medicine · 2026

* Correspondence: amabuzaid@alfaisal.edu© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-09T20:25:16.786880+00:00

DOI: 10.3390/jcm15124828 · PMC13301900